For citations:

Khoshnazar S.M., Shabanzadeh R., Yousefzadeh G. Cardiovascular risk assessment with the American Heart Association calculator in type 2 diabetes patients: A comparison of empagliflozin indications based on American and European guidelines in southeast of Iran in 2023. Diabetes mellitus. 2025;28(2):228-236. https://doi.org/10.14341/DM13153